Purchase Order HHSN263201400659P

This federal contract award to Ozgene PTY LTD, an Australian company, is for the delivery of genetically modified mice and related services to support biomedical research at various institutes and centers within the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The specific services provided under this $5,970.00 firm fixed price delivery order contract include gene targeting vector design and creation, mouse embryonic stem cell generation, blastocyst...

This is a $35,160 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), to Ozgene PTY LTD, an Australian company, for the generation of a THRB-Cre-ERT2 knock-in mouse model. The work involves designing and constructing a targeting vector, selecting recombinant embryonic stem cell clones, and generating founder mice carrying the...

This federal contract award to Ozgene Pty Ltd, an Australian company, provides genetically modified mice and related services to support biomedical research for the National Institutes of Health (NIH). The $7,286 firm fixed-price contract, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), is for the delivery of "Live Animals, Not Raised for Food" and has an ultimate completion date of April 28, 2010. Ozgene, as the prime contractor, provides gene targeting...

This federal contract award is to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The award is a $57,600.00 firm-fixed-price delivery order issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract is for the generation of a non-conditional genetically modified mouse strain,...

This is a definitive contract awarded by the National Institutes of Health (NIH) to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, valued at $38,945,214.78, is for the provision of gene targeting vectors, mouse backcrossing, and the creation of gene knockout and gene knock-in mice to support research into various diseases and disorders, such as hemoglobin disorders, red blood cell development,...

The federal contract award is to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The award was made by the National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Child Health and Human Development (NICHD), to deliver gene targeting vectors, mouse backcrossing, and the creation of gene knockout and gene knock-in mice. The...

This is a federal contract awarded by the National Institutes of Health (NIH) to the prime contractor Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, valued at $51,600.00, is for the provision of "LIVE ANIMALS, NOT RAISED FOR FOOD" and does not have a set-aside designation. Ozgene has previously received awards from various NIH institutes and centers, including the National Institute of...

This is a firm fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Gempharmatech LLC, a foreign-owned for-profit biotechnology company. The contract is for the development of a conditional knockout mouse line to support NICHD's research. The total ceiling value of the contract is $14,380.00 with a completion date of January 5, 2024. There is no set-aside...

This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, valued at $8,576.00, is for the breeding of ONO HCF-1 conditional knockout mice for removal of FLPAMBIS. No set-aside...

This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD) to Cyagen US Inc., a biotechnology company specializing in knockout and transgenic mouse models. The $97,577 contract is for Cyagen to provide "TurboKnockout" mouse gene targeting services to support biomedical research projects funded by NICHD. The contract has a completion date of June 22, 2021 and was awarded on a sole-source basis, as Cyagen's proprietary...